DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.

about

Cationic lipophosphoramidates with two different lipid chains: synthesis and evaluation as gene carriers.New Disaccharide-Based Ether Lipids as SK3 Ion Channel Inhibitors.Synthesis of Alkyl-Glycerolipids Standards for Gas Chromatography Analysis: Application for Chimera and Shark Liver Oils.

P2860

Q39032601-7BF3F40D-1A2F-4B6C-80D3-0587BB1B3778 Q51712750-66909B68-BE1A-4204-85D3-5D3E51FF192E Q53835506-2B3B7144-A1AB-4483-966E-4157A8253BDD

P2860

DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.

Item

http://www.wikidata.org/entity/Q44763170

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@en

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@nl

type

Item

label

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@en

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@nl

prefLabel

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@en

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@nl

P1476

DiGalactosyl-Glycero-Ether Lip ...... tion as SK3 channel inhibitor.

@en

P2093

Aurélie Chantôme

http://www.w3.org/2001/XMLSchema#string

Charlotte M Sevrain

http://www.w3.org/2001/XMLSchema#string

Christophe Vandier

http://www.w3.org/2001/XMLSchema#string

Hélène Couthon-Gourvès

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Haelters

http://www.w3.org/2001/XMLSchema#string

Marie Potier-Cartereau

http://www.w3.org/2001/XMLSchema#string

Maxime Gueguinou

http://www.w3.org/2001/XMLSchema#string

Paul-Alain Jaffrès

http://www.w3.org/2001/XMLSchema#string

P2860

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

Role of ion channels and transporters in cell migration

Phospholipase Cgamma1 is required for metastasis development and progression

New functions for the matrix metalloproteinases in cancer progression

Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog

Lysophospholipids open the two-pore domain mechano-gated K(+) channels TREK-1 and TRAAK.

One-pot syntheses of immunostimulatory glycolipids

Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation.

The SK3/K(Ca)2.3 potassium channel is a new cellular target for edelfosine.

Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration

P304

4479-4487

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C3OB40634B

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236957610

http://www.w3.org/2001/XMLSchema#string

P698

23715410

http://www.w3.org/2001/XMLSchema#string

DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.

about

P2860

P2860

DiGalactosyl-Glycero-Ether Lipid: synthetic approaches and evaluation as SK3 channel inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698